|
707 Society registers four main Section 60 concerns Four
main concerns about the draft Section 60 Order that sets out the future
regulatory framework for pharmacists in England, Scotland and Wales and
for pharmacy technicians in England and Wales have been reported to the
Department of Health by the Royal Pharmaceutical Society
PJ 2006;276:707
Full Text
707 Government
reviews control of entry reforms A review into the effectiveness of NHS pharmacy “control of entry” reforms introduced in April last year has been launched by the Government
PJ 2006;276:707
Full Text
707 Fines for
verbal abuse may cover community pharmacy Proposals to impose £1,000 fines on those who verbally abuse or threaten NHS staff may be extended after consultation to cover community pharmacies
PJ 2006;276:707
Full Text
708 Scottish contract
initiatives need Society support Successful delivery of services within the new pharmacy contract in Scotland will depend on robust support from the Royal Pharmaceutical Society, according to Frank Owens, chairman of the Scottish Pharmaceutical General Council
PJ 2006;276:708
Full Text
708 Naloxone pilots launched A
two-month pilot scheme to evaluate the role of naloxone in reducing drug-related
deaths will start in Lanarkshire next month
PJ 2006;276:708
Full Text
708 Price cuts do not
mean value for money, DoH is warned Department of Health plans to
reduce prices for dressings and chemical reagents will not achieve value for
money for the NHS, the National Pharmacy Association has warned
PJ 2006;276:708
Full Text
708 More money for Scottish
supplementary prescribing New funding in Scotland will allow community
pharmacists to set up or continue to run supplementary prescribing clinics
PJ 2006;276:708
Full Text
708 SMC accepts five
treatments for use by the NHS in Scotland Five treatments assessed
by the Scottish Medicines Consortium this month have been accepted for use in
the NHS in Scotland, including trastuzumab (Herceptin) for use in HER-2 positive
early breast cancer
PJ 2006;276:708
Full Text
709 CD prescribing changes
to be made in two stages Legislation to underpin a number of changes
to the prescribing and dispensing of Controlled Drugs that pharmacists were asked
to implement earlier this year starts to come into effect on 7 July
PJ 2006;276:709
Full Text
709 Commercial diets
tested Clinically beneficial weight loss is achievable through commercial
programmes, according to a recent study
PJ 2006;276:709
Full Text
709 Possible £700m of NHS savings identified NHS trusts in England have been told how they can both improve patient care and save £700m a year by increasing productivity
PJ 2006;276:709
Full Text
709 Co-op Group to stop selling “diabetic food” products The Co-operative Group has this week announced that it will no longer be stocking “diabetic foods” in its pharmacies or supermarkets
PJ 2006;276:709
Full Text
709 Diabetes services Primary care trusts should commission community pharmacies and others in the independent sector to provide services aimed at preventing diabetes, the National Clinical Director for Diabetes argues in a report this week
PJ 2006;276:709
Full Text
709 Suspension payments Primary care trusts in England and local health boards in Wales have been told how to calculate payments to be made to pharmacy contractors who have been suspended while being investigated under the NHS's new disciplinary powers
PJ 2006;276:709
Full Text
710 Nottingham top school
in Times guide Nottingham university's school of pharmacy has been ranked ahead of other UK schools of pharmacy in ‘The Times good university guide 2007’, published last week
PJ 2006;276:710
Full Text
710 Three School of Pharmacy
fellowships awarded Douglas Kinghorn, Pradip Patel and James Gemmell
have been awarded fellowships of the School of Pharmacy, University of London
PJ 2006;276:710
Full Text
710 Systematic errors
affect transfer of animal data to clinical trials False positive and
false negative results may be leading to systematic errors in the ways in which
data from animal studies are applied to clinical trials, a study suggests
PJ 2006;276:710
Full Text
711 Call for global action
to prevent spread of counterfeit artesunate An international group of researchers is calling for global efforts to prevent the spread of counterfeit artesunate — an antimalarial drug — in an article published
PJ 2006;276:711
Full Text
711 Increased awareness
of malaria prevention needed, says HPA Increased awareness about the need for malaria prophylaxis among travellers to malaria endemic regions — particularly those visiting friends or relatives — is needed following the deaths of 11 people in 2005, says the Health Protection Agency
PJ 2006;276:711
Full Text
711 Antenatal steroids
a dilemma Recommendations from a recent study of repeat versus single doses of antenatal corticosteroids, published in The Lancet last week, have been called into question by the authors of an editorial in the same issue
PJ 2006;276:711
Full Text
711 Meningitis studies
reveal limitations of observational data Suggestions of harms and benefits resulting from pre-hospital administration of antibiotics to children with suspected meningitis may be statistical artefacts, two papers suggest
PJ 2006;276:711
Full Text
711 Internet a source
of information for prescription drug misuse There is a plethora of information on the internet for potential misusers of prescription drugs, and drug companies need to consider the limitations of their own products in light of this, the author of a paper on prescription drug misuse argues
PJ 2006;276:711
Full Text
712 Warfarin remains
drug of choice in stroke prevention Oral anticoagulants, such as warfarin, are superior to aspirin plus clopidogrel in the prevention of stroke for patients with atrial fibrillation (AF), according to the results of a study published last week
PJ 2006;276:712
Full Text
712 NHS Innovations prize
for pharmacy team Pharmacy-generated lists of patients taking oral
anticoagulants have helped Winchester and Eastleigh Healthcare Trust win the
NHS Innovations South-East (IT and knowledge management) prize for 2006
PJ 2006;276:712
Full Text
712 Headlice treatment
in Wales In Wales, resistance to pyrethoids may mean that organophosphates
control head louse infections better, a study published online this week suggests
PJ 2006;276:712
Full Text
R&D NEWS
713 First-line use of
sunitinib improves survival for patients with metastatic renal cell carcinoma Sunitinib,
a new therapy for metastatic renal cell carcinoma, almost doubles progression-free
survival compared with interferon-alfa when used as a first-line treatment
PJ 2006;276:713
Full Text
713 DNA vaccines effective
in mouse model of Alzheimer's disease DNA vaccines against Alzheimer's
disease have been shown to be effective and safe in mouse models of the condition
PJ 2006;276:713
Full Text
713 Novel antidiabetic
drug as effective as glipizide and causes fewer hypoglycaemic episodes A novel investigational drug for type 2 diabetes has demonstrated similar efficacy as glipizide with greater weight loss and fewer hypoglycaemic episodes, according to interim data presented at the American Diabetes Association annual scientific sessions in Washington this week
PJ 2006;276:713
Full Text
714 Treatment options
set to expand for patients with imatinib-resistant chronic myeloid leukaemia Dasatinib
and nilotinib, novel tyrosine kinase inhibitors currently in development, induce
haematologic and cytogenetic responses in patients with imatinib-resistant leukaemias,
two studies published this week reveal
PJ 2006;276:714
Full Text
714 Sleep aid without
benzodiazepine side effects in Takeda's pipeline Ramelteon (Rozerem; Takeda), a selective melatonin receptor agonist licensed in the US last year for the treatment of insomnia, is not likely to have benzodiazepine-like abuse or dependence problems, according to researchers
PJ 2006;276:714
Full Text
714 Nitazoxanide for
rotavirus diarrhoea A three-day course of nitazoxanide — a thiazolide anti-infective agent — reduces the duration of rotavirus diarrhoea in children, new data show
PJ 2006;276:714
Full Text
714 Possible predictor
of HIV vaccine efficacy Partially effective HIV vaccines may still
convey a survival benefit, results of two studies in monkeys suggest
PJ 2006;276:714
Full Text
|
The
Pharmaceutical Journal